Veralox Therapeutics logo Veralox Therapeutics
  • About Veralox
    • Meet the Team
  • Our Approach
  • Pipeline
    • Publications
  • Company News
  • Contact

Publications

  • Hematology
  • Diabetes
  • Other
Other

High-fat diet activates liver iPLA2γ generating eicosanoids that mediate metabolic stress

Moon et al. Lipid Res. 2021;62:100052 Read More
Other

Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration

Cloutier et al. PNAS 2018;115:E1550 Read More
Other

FcγRIIA expression accelerates nephritis and increases platelet activation in system lupus erythematosus

Melki et al. Blood 2020;136:2933 Read More
Other

Modulation of gentamicin-induced acute kidney injury by myo-inositol oxygenase via the ROS/ALOX-12/12-HETE/GPR31 signaling pathway

Sharma et al. JCI Insight Read More
Other

Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA

Duchez et al. PNAS 2015;112:E3564 Read More
Other

12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy

Dong et al. Eur. J. Pharmacology 2020;879:173122 Read More
Veralox Therapeutics logo
Developing new therapies for life-threatening immuno-inflammatory diseases
Veralox Headquarters
4539 Metropolitan Ct
Frederick, MD 21704
301-360-3502
  • About Veralox
  • Our Approach
  • Pipeline
  • Team
  • Publications
  • Company News
  • Contact

Copyright 2023 | Website design by Wood Street, Inc.